Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001654954-25-009650
Filing Date
2025-08-14
Accepted
2025-08-14 16:21:40
Documents
56
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q zivo_10q.htm   iXBRL 10-Q 841212
2 CERTIFICATION zivo_ex311.htm EX-31.1 14029
3 CERTIFICATION zivo_ex312.htm EX-31.2 13689
4 CERTIFICATION zivo_ex321.htm EX-32.1 4536
5 CERTIFICATION zivo_ex322.htm EX-32.2 4547
  Complete submission text file 0001654954-25-009650.txt   4032540

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA zivo-20250630.xsd EX-101.SCH 42913
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE zivo-20250630_lab.xml EX-101.LAB 234475
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE zivo-20250630_cal.xml EX-101.CAL 37875
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE zivo-20250630_pre.xml EX-101.PRE 201083
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE zivo-20250630_def.xml EX-101.DEF 115037
59 EXTRACTED XBRL INSTANCE DOCUMENT zivo_10q_htm.xml XML 650043
Mailing Address 21 E. LONG LAKE ROAD SUITE 100 BLOOMFIELD HILLS MI 48304
Business Address 21 E. LONG LAKE ROAD SUITE 100 BLOOMFIELD HILLS MI 48304 (248) 452 9866
Zivo Bioscience, Inc. (Filer) CIK: 0001101026 (see all company filings)

EIN.: 870699977 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40449 | Film No.: 251219622
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)